- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
PLAY BUTTON
PLAY BUTTON
25 Cards in this Set
- Front
- Back
|
What family does influenza belong to?
|
Orthomyxovirus.
|
|
Describe the structure of the influenza virion and genome.
|
*helical, enveloped capsid
*genome is a (-) ssRNA divided among eight segments which are wrapped by NP |
|
What are the two significant glycoproteins on the surface of the influenza virus? What does each do?
|
*HA: mediates attachment to the cell surface via sialic acid receptors
*NA: helps the virus penetrate the respiratory mucus and cleaves sialic acid when the virus leaves the cell |
|
Where in the host cell does the replication of the influenza virus occur?
|
In the host cell nucleus.
|
|
What are the M1 and M2 proteins?
|
They are channel proteins that allow the influx of H+ into the virion which activates several cellular processes
|
|
What are the three general types of influenza virus? Give a brief description of the epidemiology of each.
|
*A - affects humans, swine, and birds; causes pandemics, most severe
*B - affects humans only, especially children; causes epidemics *C - affects humans and swine; sporadic and least severe |
|
What is antigenic drift? Why is the influenza virus prone to this phenomenon? How does this affect immunity?
|
*Slight mutational changes in the viral genome that create new serotypes
*occurs because of the high error rate of the viral RNA pol *allows evasion of immune response |
|
What is antigenic shift? How does it occur? Why do forms that undergo antigenic shift have the capacity to cause pandemic disease?
|
An entirely novel form of the influenza virus created when a single cell is infected by human and animal strains of the virus which then reassort their RNA segments. They are dangerous because there is no pre-existing immunity in the population.
|
|
What are three complications of influenza? What populations are affected by each?
|
1.Primary viral pneumonia - elderly
2.Secondary bacterial pneumonia - elderly, immunocompromised, COPD patients 3.Reye's syndrome - children who take ASA |
|
Describe the clinical course of an uncomplicated influenza infection.
|
Acute onset of fever, chills, and myalgia that is self-limiting within a few days. Cough may persist due to denuding of respiratory cilia.
|
|
How is influenza transmitted?
|
Respiratory droplets and close human-human contact.
|
|
What structure on the influenza virus is most often targeted by neutralizing antibodies?
|
The HA protein.
|
|
What is the mechanism of action of amantidine and rimantidine? Against which form of influenza are they most effective? How are they different?
|
*they inhibit the M2 channel protein to prevent uncoating
*influenza A *rimantidine usually has fewer CNS side effects |
|
Where in the body is viral replication initiated?
|
In the superficial cells of the respiratory tract.
|
|
From what part of the world have most pandemic strains of influenza arisen? Why is this?
|
From Asia because farming practices place swine, avian, and human vectors in close proximity. Similar conditions are emerging in Central and South America.
|
|
What are two neuraminidase inhibitors available for treatment of influenza? When must these medications be started to be at all effective?
|
*oseltamivir (Tamiflu) and zanamivir (Relenza)
*within 2 days of symptom onset |
|
What are the 2 kinds of vaccine for influenza? What kind of immunity do these vaccines induce?
|
1.Injectable killed virus form that contain HA antigen from the three most prevalent strains
2.Trivalent inhaled live attenuated form *6-12 month humoral immunity |
|
What family does RSV belong to? Describe its virion and genome structure.
|
*paramyxovirus
*helical nucleocapsid surrounded by an envelope *genome is (-) ssRNA |
|
What glycoprotein does RSV use to bind its receptor on the host cell? What glycoprotein does RSV use to penetrate the host cell membrane?
|
*G glycoprotein is used to bind host cell receptor
*F glycoprotein is used to mediate fusion and thus penetration of the host cell membrane |
|
What histological feature is characteristic of RSV?
|
The formation of a syncytium (multinucleated giant cells).
|
|
What patient population is most affected by RSV? How is infection manifested in these persons?
|
Infants less than 6 months of age present with severe LRT infections with bronchiolitis and pneumonia. Note that immunosupressed persons of all ages may have a more serious course.
|
|
How is RSV spread? Is it seasonal?
|
The virus is spread by close contact and respiratory secretions and may survive for several hours outside of the body. Epidemics are usually in the mid-winter to late spring.
|
|
What difficulties have been encountered in the development of a vaccine for RSV?
|
It is difficult to elicit a strong immune response in infants because of immaturity of their own immune systems and the presence of maternal antibodies. Also the current vaccine cause a more robust response in subsequent infections.
|
|
How is RSV treated? Are there any prophylactic measure?
|
Treatment is mostly suppportiive and symptomatic. Ribavirin has been used with mixed results. Immunoglobulin can be used as a prophylactic measure but there is no vaccine.
|
|
Why are both secretory and serum antibody important in immunity against RSV?
|
Secretory IgA helps to prevent the URT from infection while serum antibodies prevent infection in the LRT.
|
